Fresenius SE & Co KGaA (FRE) Given a €53.00 Price Target by Jefferies Financial Group Analysts

Jefferies Financial Group set a €53.00 ($61.63) target price on Fresenius SE & Co KGaA (FRA:FRE) in a report released on Thursday morning, Borsen Zeitung reports. The firm currently has a neutral rating on the stock.

Several other brokerages also recently commented on FRE. Kepler Capital Markets set a €62.00 ($72.09) price objective on shares of Fresenius SE & Co KGaA and gave the company a buy rating in a research report on Monday, March 11th. Berenberg Bank set a €70.95 ($82.50) price objective on shares of Fresenius SE & Co KGaA and gave the company a buy rating in a research report on Wednesday, April 24th. HSBC set a €58.00 ($67.44) price objective on shares of Fresenius SE & Co KGaA and gave the company a neutral rating in a research report on Thursday, April 25th. Credit Suisse Group set a €45.00 ($52.33) price objective on shares of Fresenius SE & Co KGaA and gave the company a neutral rating in a research report on Wednesday, January 23rd. Finally, Deutsche Bank set a €65.00 ($75.58) price objective on shares of Fresenius SE & Co KGaA and gave the company a buy rating in a research report on Tuesday, April 9th. Ten research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. The company has a consensus rating of Buy and an average price target of €59.23 ($68.88).

Shares of FRE stock opened at €51.43 ($59.80) on Thursday. Fresenius SE & Co KGaA has a one year low of €60.16 ($69.95) and a one year high of €80.00 ($93.02).

Fresenius SE & Co KGaA Company Profile

Fresenius SE & Co KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed segments. The Fresenius Medical Care segment offers products for patients with chronic kidney failure.

Recommended Story: Trading Options- What is a Strangle?

Analyst Recommendations for Fresenius SE & Co KGaA (FRA:FRE)

Receive News & Ratings for Fresenius SE & Co KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co KGaA and related companies with MarketBeat.com's FREE daily email newsletter.